Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
WARNING: For adults only
See the FDA regulatory context section below before making your decision
Clinical Studies 14.1 Attention Deficit Hyperactivity Disorder (ADHD) Pediatric Patients Ages 6 to 12 Years with ADHD A double-blind, randomized, placebo-controlled, parallel-group study (Study 1) was conducted in pediatric patients ages 6 to 12 years (N=290) who met DSM-IV criteria for ADHD (either the combined type or the hyperactive-impulsive type)
Similarly, patients prescribed SGLT2 inhibitors both before and after the procedure increased substantially from 0.9% in 2018 to 4.3% in 2023, once again calling into question the extent to which SGLT2 inhibitors are a replacement versus a supplemental therapy
US$ 26.61
US$ 23.31
US$ 20.51
US$ 21.04
US$ 29.34
